Screener
Myriad Genetics MYGN Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Myriad Genetics’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 6:05 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000899923-26-000038
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Accounts payable | $32.6 | $30.0 |
| Accrued liabilities | 90.5 | 96.9 |
| Current maturities of operating lease liabilities | 7.1 | 6.9 |
| Total current liabilities | 130.2 | 133.8 |
| Long-term debt | 120.3 | 119.9 |
| Noncurrent operating lease liabilities | 84.1 | 83.0 |
| Other long-term liabilities | 1.7 | 1.9 |
| Total liabilities | 336.3 | 338.6 |
Item 1. Financial Statements.
FAQ
- What is Myriad Genetics's total current liabilities?
- Myriad Genetics (MYGN) reported total current liabilities of $130.2M in Q1 2026.
- How has Myriad Genetics's total current liabilities changed year-over-year?
- Myriad Genetics's total current liabilities decreased by 13.8% year-over-year, from $151.1M to $130.2M.
- What is the long-term trend for Myriad Genetics's total current liabilities?
- Over 5 years (2020 to 2025), Myriad Genetics's total current liabilities has grown at a -1.7% compound annual growth rate (CAGR), from $145.9M to $133.8M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Myriad Genetics's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude